@Patience87 I was reading back through some of @ecoool2's posts; (i don't remember which one) where he discusses the reasoning behind entry into the nasdaq rebalance on the 18th december.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-689
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.070(5.02%) |
Mkt cap ! $1.621B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $4.345M | 3.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1161 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 13394 | 3 |
View Market Depth
| Last trade - 13.24pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |